SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Valeant Squirms as Endo International Makes Competing Offer for Salix
March 11, 2015
 · 
4 min read
Biowarfare Company Emergent's Cancer Spinoff Aptevo Therapeutics to Employ 70 - 90 in Seattle
Deals
Ackman Gobbles Up Almost Five Percent Stake in Valeant
March 10, 2015
 · 
5 min read
Job Trends
Valeant Starts Chopping Dendreon Employees
March 3, 2015
 · 
2 min read
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
Biotech Bay
EXCLUSIVE: Evercore ISI Breaks Down Valeant / Salix Deal By the Numbers
February 23, 2015
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Spending Spree Continues as Valeant Officially Snags Salix for $14.5 Billion
February 22, 2015
 · 
4 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Deals
Endo Pharmaceuticals Rumored to be Battling Shire, Valeant for Salix’s Affections
February 18, 2015
 · 
2 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Deals
Look Out Valeant, Shire Wants to Continue Spending Spree With Salix Bid
February 13, 2015
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Valeant Secures Financing to Make Rumored $9.6 Billion Bid for Salix
February 12, 2015
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
It’s Official: Valeant to Buy Bankrupt Vaccine Maker for $400 Million Cash
February 11, 2015
 · 
2 min read
Load More
IN THE PRESS
Bausch Health Announces Closing Of Incremental Amendment To Its Existing Credit Agreement And Redemption Of Its 7.500% Senior Notes Due 2021
November 27, 2018
 · 
3 min read
Policy
Perrigo Confirms Patent Challenge for Generic Version of Jublia® Topical Solution 10%
October 1, 2018
 · 
5 min read
Business
Ekso Bionics Appoints Jack Glenn as Chief Financial Officer
August 13, 2018
 · 
4 min read
Drug Development
Strategic appointment expands Atlantic Healthcare executive team
August 8, 2018
 · 
7 min read
Policy
Virtus Thwarts Efforts of Bausch Health (formerly known as Valeant) to Push Lower Priced Competing Drugs off the Market
August 1, 2018
 · 
1 min read
Business
Bausch Health Companies Inc. Completes Name Change
July 13, 2018
 · 
3 min read
FDA
Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%
July 9, 2018
 · 
3 min read
FDA
FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion
June 18, 2018
 · 
3 min read
Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops
June 14, 2018
 · 
4 min read
Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins
June 12, 2018
 · 
4 min read
Load More